| Bioactivity | BM-131246 is an oral antidiabetic agent. |
| In Vivo | BM-131246 is absorbed quickly and attains approximately proportional increase of the plasma levels in ob/ob mice. After repeated oral doses the terminal half-lives is about 4 h for BM-131246[1]. |
| Name | BM-131246 |
| CAS | 103787-97-9 |
| Formula | C22H20N2O4S |
| Molar Mass | 408.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Heitzmann T, et al. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice. Arzneimittelforschung. 1995 Dec;45(12):1284-8. |